Assay of creatine kinase isoenzyme MB in serum with time-resolved immunofluorometry

5Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We describe the first time-resolved immunofluorometric assay for creatine kinase (EC 2.7.3.2) isoenzyme MB (CK-MB) in serum. The assay is based on the formation of the complex: solid-phase anti-CK-MB-CK-MB-biotinylated anti-CK-BB-streptavidin-BCPDA-Eu3+, where anti-CK-MB and anti-CK-BB are monoclonal antibodies against the CK isoenzymes MB and BB, respectively, and BCPDA is the europium chelator 4,7-bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid. The solid-phase complex is fluorescent and is measured on the dry solid-phase (microtiter well) in a specially designed time-resolved fluorometer that uses laser excitation. The assay requires 25 μL of serum and is not affected by the presence of either CK-MM (up to 5000 μg/L) or CK-BB (up to 1000 μg/L) in the sample. Precision and accuracy indices for the assay were satisfactory.

Cite

CITATION STYLE

APA

Lianidou, E. S., Christopoulos, T. K., & Diamandis, E. P. (1990). Assay of creatine kinase isoenzyme MB in serum with time-resolved immunofluorometry. Clinical Chemistry, 36(9), 1679–1683. https://doi.org/10.1093/clinchem/36.9.1679

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free